We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Alcon AG (ALC) Ord CHF0.04

Sell:76.42 CHF Buy:76.46 CHF Change: 0.44 CHF (0.58%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:76.42 CHF
Buy:76.46 CHF
Change: 0.44 CHF (0.58%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:76.42 CHF
Buy:76.46 CHF
Change: 0.44 CHF (0.58%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Contact details

Address:
Rue Louis d'Affry 6
FRIBOURG
1701
Switzerland
Telephone:
+ ()
Website:
https://www.alcon.ch/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALC
ISIN:
CH0432492467
Market cap:
38.28 billion CHF
Shares in issue:
494.50 million
Sector:
Health Care Supplies
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • David Endicott
    Chief Executive Officer, Director
  • Timothy Stonesifer
    Chief Financial Officer
  • Ian Bell
    President - Global Business and Innovation
  • Leon Duplan Fraustro
    President, North America
  • Rajkumar Narayanan
    President - International
  • Sue-Jean Lin
    Senior Vice President, Chief Information and Transformation Officer
  • Laurent Attias
    Head of Corporate Development, Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.